Are there generic versions of Brigatinib?

Brigatinib/Brigatinib (Brigatinib) is a drug used to treat non-small cell lung cancer (NSCLC). It belongs to a category of targeted therapy drugs, acting on the fusion gene ALK (ALK) on tumor cells. This gene fusion often occurs in some patients with NSCLC, causing the tumor cells to grow and spread excessively.

The mechanism of action of Brigatinib/Brigatinib is by inhibiting ALK fusion protein and blocking cell signaling, thereby inhibiting tumor growth and spread. It can bind to ALK on tumor cells, block its activation, and inhibit cell proliferation and survival. In addition, Brigatinib/Brigatinib also has the ability to target some common resistance mechanisms, such as T790M mutation.

Before using brigatinib / brigatinib , patients need to undergo genetic testing to confirm whether there is ALK rearrangement. If a patient is ALK rearrangement-positive, doctors may consider brigatinib/brigatinib as part of the treatment regimen.

Brigatinib/Brigatinib is a prescription drug that can only be used under the guidance of a doctor. During use, patients need to follow the doctor's advice, take medication according to the prescribed dosage and schedule, and conduct regular monitoring and follow-up.

Brigatinib/Brigatinib has been launched in China and has been included in medical insurance. Since it has just been approved for marketing, patients may not be able to buy it in domestic pharmacies. If you need to purchase it in China, please consult the local pharmacy. However, the price is quite high, more than 10,000 yuan. ForeignBrigatinib/布格替尼主要是仿制药，主要是孟加拉和老挝仿制药，孟加拉仿制药耀品国际版价格大约2000元左右，规格90mg*30片；老挝版仿制药价格大约在600左右，规格要少一些。 And the ingredients of domestic original drugs and foreign generic drugs are basically the same.